Adipocytokines: The pied pipers

Area of Science:

• Biochemistry
• Endocrinology
• Cardiovascular Medicine

Background:

• Atherosclerosis and coronary artery disease remain leading causes of mortality.
• Diabetes, obesity, and insulin resistance are significant co-morbidities.
• Adipose tissue releases bioactive proteins called adipocytokines that impact metabolic and inflammatory processes.

Purpose of the Study:

• To review the role of key adipocytokines in metabolic and cardiovascular diseases.
• To highlight the involvement of adiponectin, resistin, RBP-4, visfatin, and leptin.
• To discuss potential therapeutic implications of modulating adipocytokine levels.

Main Methods:

• Literature review of adipocytokines and their associated pathologies.
• Analysis of the molecular mechanisms of adipocytokines like adiponectin and resistin.
• Examination of the link between adipocytokines and conditions such as insulin resistance, obesity, and atherosclerosis.

Main Results:

• Adiponectin exhibits anti-inflammatory actions, enhances insulin sensitivity, and ameliorates obesity.
• Resistin promotes inflammation and is implicated in insulin resistance and myocardial infarction pathophysiology.
• RBP-4 is linked to type 2 diabetes and obesity; visfatin is an inflammatory cytokine; leptin regulates energy homeostasis but leptin resistance contributes to obesity.

Conclusions:

• Adipocytokines play a crucial role in the pathogenesis of metabolic and cardiovascular diseases.
• Modulating adipocytokine levels through drugs or lifestyle changes may offer therapeutic benefits.
• Further research is needed to fully explore the therapeutic potential of targeting adipocytokines.